findmyKOL
Clinical trialNCT00776503CompletedPhase 1/PHASE2Interventional

Vorinostat and Low Dose Cytarabine for High Risk Myelodysplasia

SponsorGroupe Francophone des MyelodysplasiesEnrollment52Myelodysplastic Syndromes
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

France
  • Hôpital de la Durance

    Avignon, France

  • Hopital Avicenne

    Bobigny, France

  • Ch René Dubos

    Cergy-Pontoise, France

  • Hematology Dpt, Hôpital Sud Francilien

    Corbeil-Essonnes, France

  • Chu Grenoble

    Grenoble, France

  • Hôpital Edouard Heriot, Dpt Hématologie Clinique

    Lyon, France

  • Hematology Dpt, Institut Paoli Calmettes

    Marseille, France

  • Hematology Dpt, Hopital de L'Hotel Dieu

    Nantes, France

  • Hematology Dpt, Hopital Cochin

    Paris, France

  • Hematology Dpt, Hopital Saint Louis

    Paris, France

  • Centre Henri Bequerel

    Rouen, France

  • Centre René Huguenin

    Saint-Cloud, France

  • Hematology Dpt, Hopital Haute Pierre

    Strasbourg, France

  • Hematology Dpt, Hopital Purpan

    Toulouse, France

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2008
Primary completion
30 Nov 2011
Completion
30 Nov 2011
Last update posted
20 Mar 2014
Registered enrollment
52
Registry id
NCT00776503
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.